Skip to content

Public FDA record

Z-1386-05: Amvisc Plus Sodium Hyaluronate 0.5 mL. Bausch & Lomb, Inc., Rochester, NY Product Number: 60051

Recall record Z-1386-05 for Anika Therapeutics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1386-05
Company in FDA record
Anika Therapeutics, Inc.
FDA classification date
Aug 23, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Product sterility may be compromised due incomplete heat seals in the cannula pouches that are included with the viscoelastic syringe.

Source facts

Action
Anika Therapeutics notified Distributor accounts by telephone on July 14. The letters were faxed and sent by Fedex on July 14. Distributors were provided with a end-user letter template letter for notification to their accounts.
Initiated
2005-07-14
Root cause
Other
Terminated
2006-05-02
Distribution
CA, NC
Recall number
Z-1386-05
Recall status
Terminated
CDRH record ID
40768
FDA classified
2005-08-23
Recall event number
32711

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗